Navigation Links
Barr Confirms Patent Challenge of Avodart(R) Soft Gelatin Capsules, 0.5mg
Date:2/26/2008

MONTVALE, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by GlaxoSmithKline in connection with its Avodart(R) (dutasteride) soft gelatin capsules, 0.5mg. The Company believes that it is the first to file an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for Avodart.

Barr filed its ANDA containing a paragraph IV certification for a generic Avodart product with the U.S. Food & Drug Administration (FDA) in October 2007, and received notification of the application's acceptance for filing in January 2008. Following receipt of the notice from the FDA that Barr's ANDA had been accepted for filing, Barr notified the New Drug Application (NDA) and patent holder.

On February 25, 2008, GlaxoSmithKline filed suit in the U.S. District Court for the District of Delaware to prevent Barr from proceeding with the commercialization of its product. This action formally initiates the patent challenge process under the Hatch-Waxman Act.

Avodart (dutasteride) had annual sales of approximately $362 million in the U.S., based on IMS sales data for the twelve-month period ending December 2007.

About Barr Pharmaceuticals, Inc.

Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. A holding company, Barr operates through its principal subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidi
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Icahn Confirms Intention to Nominate Three Directors at Biogen
2. Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg
3. Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL
4. Barr Confirms Patent Challenge of Focalin(R) XR
5. Recent Study Confirms Alimentary Healths Bifantis(R) Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome
6. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
7. Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
8. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
9. Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements
10. United States Patent Office Grants CryoCors Request for Patent Interference
11. AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Innovation is more urgent than ... parts of the world and transforming global markets ... manufacturing to health care, disruption is constantly underway. ... socio-political trends shake the foundations of established business ... CEOs to survive the next wave of mega-change. ...
(Date:2/26/2015)... 2015 Regis Technologies announced new ... oncology drug substances. , Regis Technologies is proud to ... Potent Compound Suite (PCS) for 2015. , Regis is ... cGMP facility in Morton Grove, Illinois. The PCS addition ... compounds up to about one kilogram per batch. ...
(Date:2/26/2015)... 26, 2015   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... at the Cowen 35 th Annual Health Care Conference ... Boston .  Lexicon management will provide an ... A webcast of the presentation will be available through Lexicon,s ... presentation will be available at www.lexpharma.com until April ...
(Date:2/26/2015)... IRVING, Texas , Feb. 26, 2015 /PRNewswire/ ... of two posters, at the 2015 Genitourinary Cancers ... that highlight the clinical utility of tumor profiling. ... panomic, comprehensive tumor profiling service, to identify biomarkers ... metastatic prostate cancer and small cell bladder cancer ...
Breaking Biology Technology:One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2Regis Extends cGMP Services to Oncology Market 2Lexicon To Present At The Cowen 35th Annual Health Care Conference 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 3Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 4Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 5
... are the top 10 reasons to be at the Biotechnology Industry ... some great toys for the kids. Attention-grabbing baubles are the ... of 61 nations and 48 states have set up shop. Mini-soccer ... , Crowd at BIO 9. You can ...
... Thursday that Joe Hogan, head of GE Healthcare Technologies in ... in London next year as part of the parent ... ,Hogan will succeed Bill Castell as head of GE Healthcare ... of the Waukesha-based GE Healthcare Technologies division since 2000, when ...
... proposed ban on all forms of human cloning in Wisconsin. ... for reproductive purposes and for what practitioners have called research ... the purpose of extracting stem cells. Penalties for violating the ... to ten years in prison and $1 million in fines. ...
Cached Biology Technology:From the BIO floor 2From the BIO floor 3
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America recently ... for carbon nanotube (CNT) macrostructures, including sheets, yarns and ... (UTD). Leveraging the vast industrial resources of ... Japan , Lintec of America is forming the ... TX , focusing on scaling up the manufacturing ...
(Date:2/5/2015)... OXFORD, Conn. , Jan. 26, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... a new corporate website ( http://www.nxt-id.com/ ) as part ... Wocket™ smart wallet. The Company launched its new consumer ... Gino Pereira , CEO of NXT-ID said, "Our ...
(Date:2/5/2015)... 2015 Research and Markets ( ... "Global Biometrics Market (2014-2020): Market Forecast By ... report to their offering. , ... is anticipated to overtake North ... government spending towards IT security, government biometric based ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
... 2007 Bats are the most vocal mammals other ... nocturnal outings could lead to better treatments for human ... Thousands of bats native to Central Texas fly overhead ... at frequencies too high for humans to hear. ...
... October 17, 2007. -- It all started as a graduate ... to figure out why things live where they do, says ... Ive been studying the distribution of vegetation species for more ... basis of my masters and doctorate theses back in the ...
... almost upon us and increasing concerns about the ... it is timely that researchers should turn their ... in a forthcoming issue of the Inderscience publication ... researchers suggest a new approach to cutting journey ...
Cached Biology News:Researchers studying how singing bats communicate 2Neilson member of Nobel Prize-winning panel of scientists 2Computer solution to delivery problem 2
Mouse monoclonal antibody raised against a partial recombinant DENR. NCBI Entrez Gene ID = DENR...
Mouse monoclonal antibody raised against a partial recombinant CRKRS. NCBI Entrez Gene ID = CRKRS...
... The BD PhosFlow Perm/Wash Buffer I ... post-translationally modified signaling proteins to permeabilize cells ... and cell wash buffer. Because saponin-mediated cell ... important to keep the cells in the ...
Mouse monoclonal antibody raised against a full length recombinant GPT. NCBI Entrez Gene ID = GPT...
Biology Products: